Sightline Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,685
| Closed | -$329K | – | 61 |
|
|
2022
Q3 | $329K | Sell |
9,685
-4,908
| -34% | -$167K | 0.39% | 41 |
|
|
2022
Q2 | $456K | Sell |
14,593
-3,679
| -20% | -$115K | 0.45% | 32 |
|
|
2022
Q1 | $839K | Sell |
18,272
-631
| -3% | -$29K | 0.7% | 21 |
|
|
2021
Q4 | $1.15M | Buy |
18,903
+4,985
| +36% | +$304K | 1.03% | 15 |
|
|
2021
Q3 | $1.04M | Buy |
13,918
+3,675
| +36% | +$275K | 0.87% | 18 |
|
|
2021
Q2 | $947K | Buy |
10,243
+4,008
| +64% | +$371K | 0.78% | 18 |
|
|
2021
Q1 | $556K | Sell |
6,235
-235
| -4% | -$21K | 0.51% | 32 |
|
|
2020
Q4 | $603K | Buy |
+6,470
| New | +$603K | 0.59% | 31 |
|